LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
11,501,556
Share change
+330,188
Total reported value
$97,668,562
Price per share
$8.46
Number of holders
42
Value change
+$2,810,965
Number of buys
22
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q2 2020

As of 30 Jun 2020, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,501,556 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., SAMLYN CAPITAL, LLC, FRANKLIN RESOURCES INC, BlackRock Inc., Lion Point Capital, LP, JPMORGAN CHASE & CO, VANGUARD GROUP INC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.